The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Akorn Inc

Nasdaq: AKRX
Last

(U.S.) $46.16

Today's change0.00 0.00%
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

Akorn Inc

Nasdaq: AKRX
Last

(U.S.) $46.16

Today's change0.00 0.00%
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.

Akorn Inc closed at (U.S.)$46.16.

Over the last five days, shares are unchanged, but have gained 27.51% over the last year to date. This security has outperformed the S&P 500 by 26.78% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $46.16
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.00 / (U.S.) $47.22
  • YTD % change+27.51%
  • Volume0
  • Average volume (10-day)964,409
  • Average volume (1-month)1,152,520
  • Average volume (3-month)1,541,378
  • 52-week range(U.S.) $31.85 to (U.S.) $57.10
  • Beta0.76
  • Trailing P/E142.26×
  • P/E 1 year forward23.53×
  • Forward PEG1.09×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.32
Updated August 3 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.04%

Based on its net profit margin of 6.04%, Akorn Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue22813314291
Total other revenue--------
Total revenue22813314291
Gross profit128526850
Total cost of revenue99817441
Total operating expense15613812667
Selling / general / administrative29282217
Research & development8894
Depreciation / amortization171495
Interest expense (income), net operating--------
Unusual expense (income)37120
Other operating expenses, total--------
Operating income72-51623
Interest income (expense), net non-operating-1-3-2-6
Gain (loss) on sale of assets--------
Other--------
Income before tax57-19516
Income after tax34-12310
Income tax, total22-726
Net income34-12310
Total adjustments to net income--------
Net income before extra. items34-12310
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items34-12310
Inc. avail. to common incl. extra. items34-12310
Diluted net income40-12310
Dilution adjustment6------
Diluted weighted average shares124105118117
Diluted EPS excluding extraordinary itemsvalue per share0.32-0.110.030.08
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.34-0.070.090.09